Trump's administration argued that people within the US pay "massively higher prices" for the same drug compared to other rich countries. (Photo: Wikimedia Commons) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Pfizer's stock price went up nearly 2% or 1.91% on Tuesday as US President Donald Trump announced a price deal with vaccine maker. The pharma manufacturer is expected to sell its drugs at a lower price to the US Medicaid Insurance Program as part of an anticipated deal with Trump to push forward his "most-favoured nations" policy, Washington Post reported.

This policy involves US residents paying for a prescription drug at an amount that is comporable to what is paid in the developing countries and not any higher.

Trump's administration argued that people with

See Full Page